U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07764653) titled 'Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer' on July 27.
Brief Summary: The aim of the study is a prospective multicentre phase-3 study that aims to evaluate the detection rate of sentinel lymph node in patients with breast cancer.
To compare the detection rates of Technetium Tc 99m Sulfur Colloid Injection(99mTc-SC) and Mitoxantrone Hydrochloride Injection for Tracing(MHI) for lymphatic tracing in patients with breast cancer.
Study Start Date: Jan. 02, 2024
Study Type: INTERVENTIONAL
Condition:
Sentinel Nodes
Breast Cancer
Intervention:
DRUG: Technetium Tc 99m Sulfur Colloid Injecti...